Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (268)

« Back to Publications

Economic effects for citizens and the government of a country-level tobacco endgame strategy: a modelling study.

Ait Ouakrim D. et al, (2025), Tob Control, 34, e9 - e16

Flash glucose monitoring for Indigenous Australians with type 2 diabetes: a randomised pilot and feasibility study

Eer AS. et al, (2025), Pilot and Feasibility Studies, 11

International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL.

Clarke PM. et al, (2025), Diabetes Care, 48, 1925 - 1931

Accuracy of online surveys in predicting COVID-19 uptake and demand: A cohort study investigating vaccine sentiments and switching in 13 countries from 2020 to 2022.

Abel ZDV. et al, (2025), Vaccine, 62

Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy.

Singh S. et al, (2025), Value Health, 28, 988 - 992

Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial

Zhou J. et al, (2025), EClinicalMedicine

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Roope LSJ. et al, (2025), Contemp Clin Trials Commun, 45

Development and Validation of the Patient-Level Chinese Diabetes Outcome Model on Long-term Complications in Type 2 Diabetes: An Application of the Hong Kong Diabetes Register.

Lau ESH. et al, (2025), Diabetes Care, 48, 579 - 587

Inequality in COVID-19 vaccine acceptance and uptake: A repeated cross-sectional analysis of COVID vaccine acceptance and uptake in 13 countries.

Abel ZD. et al, (2025), Health Policy, 153

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Jones DA. et al, (2025), Br J Haematol, 206, 531 - 540

Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes.

Jenkins AJ. et al, (2025), Intern Med J, 55, 148 - 153

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trial.

Halliday JA. et al, (2024), BMJ Open Diabetes Res Care, 12

Willingness to participate in placebo-controlled surgical trials of the knee.

Wall L. et al, (2024), Bone Joint J, 106-B, 1408 - 1415

The impact of winning funding on researcher productivity, results from a randomized trial

Barnett A. et al, (2024), Science and Public Policy, 51, 1042 - 1050

Economic costs attributable to modifiable risk factors: an analysis of 24 million urban residents in China.

Xiong X. et al, (2024), BMC Med, 22

Load More

1
2
3
4
5
6
7
...
»